Work

Development of B-cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.2542

Authors: Jooeun Bae, Shuichi Kitayama, Zach Herbert, Laurence Daheron, Nikhil C. Munshi, Shin Kaneko, Jerome Ritz, Kenneth Carl Anderson

Institutions: Dana-Farber Cancer Institute, Harvard University, Dana-Farber/Harvard Cancer Center, Kyoto University, Center for iPS Cell Research and Application, Kyoto University

Language: English

Topic: Pluripotent Stem Cells Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281725796

Cites:

Cited by:

Related to: 10